Skip to content

Need to talk? Call or text 988 (US)

RecurrentDepression

Topic

Schizophrenia

8 articles

FDA approves Otsuka and Lundbeck's schizophrenia treatment
Schizophrenia

FDA approves Otsuka and Lundbeck’s schizophrenia treatment

The U.S. Food and Drug Administration approved Danish drugmaker H. Lundbeck A/S and Japan’s Otsuka Pharmaceutical Co Ltd’s Rexulti, an anti-psychotic drug used to treat schizophrenia. The drug, brexpiprazole, was also approved as an adjunctive therapy for major depressive disorder

3 min read

Personalized Schizophrenia Treatment on the Way?
Schizophrenia

Personalized Schizophrenia Treatment on the Way?

Although schizophrenia patients with the 22q11.2 gene deletion (22q11.2DS) respond to clozapine (multiple brands) at a lower dose than other patients, they experience more serious adverse events, say Canadian researchers in findings that may pave the way for personalized medicine

6 min read

Schizophrenia

Schizophrenia and Other Psychoses

Childhood-onset schizophrenia is a severe form of psychotic disorder that occurs at age 12 years or younger and is often chronic and persistently debilitating. The definition of childhood schizophrenia has evolved over time and is now believed to be a

21 min read

Schizophrenia

Minimal – medication approaches to treating schizophrenia

UK guidelines for treating people diagnosed with schizophrenia currently emphasise the primacy of antipsychotic medication, with or without psychosocially based interventions as circumstances dictate. We now see increasing calls, most notably from mental health service users, for the provision of

34 min read

Schizophrenia

IQ tests as aids to diagnosis and management in early schizophrenia

Intellectual and other more specific neurocognitive impairments in schizophrenia are important for understanding the aetiology of the condition and its likely outcome. However, these impairments are not usually considered important for supporting a diagnosis in suspected early schizophrenia. IQ testing

23 min read

Schizophrenia

Lifestyle and physical health in schizophrenia

People with schizophrenia die prematurely. Their illness, its treatment and their lifestyle all contribute to the excess morbidity and mortality. Lifestyle ‘choices’ (e.g. poor diet, low rates of physical activity and increased likelihood to smoke cigarettes) predispose them to poor

35 min read

If you need help now

Reaching out is a sign of strength.

If you are thinking about suicide or worried about someone, talk to someone today. In an emergency, call your local emergency number.